Browse by Aston Author

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | Date | No Grouping
Number of items: 15.

Article

Santos, Ana Rita; Ribeiro, Luísa; Bandello, Francesco; Lattanzio, Rosangela; Egan, Catherine; Frydkjaer-Olsen, Ulrik; García-Arumí, José; Gibson, Jonathan; Grauslund, Jakob; Harding, Simon P.; Lang, Gabriele E.; Massin, Pascale; Midena, Edoardo; Scanlon, Peter; Aldington, Stephen J.; Simão, Sílvia; Schwartz, Christian; Ponsati, Berta; Porta, Massimo; Costa, Miguel Ângelo; Hernández, Cristina; Cunha-Vaz, José; Simó, Rafael and , European Consortium for the Early Treatment of Diabetic Retinopa (2017). Functional and structural findings of neurodegeneration in early stages of diabetic retinopathy:cross-sectional analyses of baseline data of the EUROCONDOR project. Diabetes, 66 (9), pp. 2503-2510.

Foss, Alexander J.E.; Scott, Lauren J.; Rogers, Chris A.; Reeves, Barney C.; Ghanchi, Faruque; Gibson, Jonathan; Chakravarthy, Usha and , IVAN study group (2016). Changes in intraocular pressure in study and fellow eyes in the IVAN trial. British Journal of Ophthalmology, Online ,

Gibson, Jonathan (2014). Jonathan Gibson. Concordia, Summer , pp. 6-7.

Al-Husainy, Sahar and Gibson, Jonathan (2014). Management of diabetic macular edema in the UK National Health Service. Retina today, 9 (3), pp. 75-76.

Mirza, Zahir; Sreekanth, Sreekantam; Gibson, Jonathan and Dasgupta, Indranil (2013). Optical coherence tomography confirmed resolution of macular edema in a diabetic patient after hemodialysis. Retinal cases and brief reports, 7 (3), pp. 245-247.

Calcagni, Antonio and Gibson, Jonathan (2013). Imaging of the human fundus in the clinical setting:past present and future. US Ophthalmic Review, 6 (1), pp. 42-47.

Hanratty, Michelle and Gibson, Jonathan (2013). Dry AMD:the neglected disease. Optometry Today, 53 (4), pp. 47-51.

Silva, Rufino; Axer-Siegel, Ruth; Eldem, Bora; Guymer, Robyn; Kirchhof, Bernd; Papp, Andras; Seres, Andras; Gekkieva, Margarita; Nieweg, Annette; Pilz, Stefan and Gibson, Jonathan (2013). The SECURE study:long-term safety of Ranibizumab 0.5 mg in neovascular age-related macular degeneration. BMC Ophthalmology, 120 (1), pp. 130-139.

Gibson, Jonathan (2009). Screening for eye disease in the elderly:is it worth it? British journal of hospital medicine, 70 (10), pp. 554-555.

Burton, Amy; Shaw, Rachel and Gibson, Jonathan Experiences of patients with age-related macular degeneration receiving anti-vascular endothelial growth factor therapy:a qualitative study. British Journal of Visual Impairment, 31 (3), pp. 178-188.

Pearce, Ian; Banerjee, Sanjiv; Burton, Ben; Chakravarthy, Usha; Downey, Louise; Gale, Richard; Gibson, Jonathan; Pagliarini, Sergio; Patel, Jignesh; Sivaprasad, Sobha; Andrews, Chis; Brittain, Chris and Warburton, James Ranibizumab 0.5 mg for diabetic macular edema with bimonthly monitoring after a phase of initial treatment:18-month, multicenter, phase IIIB RELIGHT study. Ophthalmology, 122 (9), 1811–1819.

Gibson, Jonathan and McGinnigle, Samantha Recent advances in topical therapeutics for vitreoretinal diseases. US Ophthalmic Review, 8 (1), pp. 2-7.

Gibson, Jonathan A review of the NICE guidance for the treatment of diabetic macular oedema. British Journal of Health Care Management, 21 (11), pp. 502-504.

Conference or Workshop Item

Chambers, Hayley; Balu, Shoba; Wharton, Helen; Dodson, Paul D. and Gibson, Jonathan Is it safe to increase diabetic retinopathy screening intervals in patients with no/background diabetic retinopathy? IN: Royal College of Ophthalmologists annual congress 2013. Arena & Convention Centre, 2013-05-21 - 2013-05-23.

Miah, J.; Dodson, P.M.; Gibson, Jonathan; Clarke, Margaret and Ateeq, Saeed Optic Disc Haemorrhage (ODH) audit:should morphology determine referral? IN: Royal College of Ophthalmologists annual congress 2013. Arena & Convention Centre, 2013-05-21 - 2013-05-23.

This list was generated on Thu Nov 23 00:57:54 2017 GMT.